Skip to main content
Clinical and Vaccine Immunology : CVI logoLink to Clinical and Vaccine Immunology : CVI
. 2012 Sep;19(9):1480–1486. doi: 10.1128/CVI.00234-12

Development and Application of a Double-Antigen Sandwich Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Porcine Circovirus 2

Meng Ge 1, Wei Luo 1, Daliang Jiang 1, Runcheng Li 1, Wenwei Zhao 1, Guoliang Chen 1, Xingdong Yang 1, Xinglong Yu 1,
PMCID: PMC3428405  PMID: 22815145

Abstract

A double-antigen sandwich enzyme-linked immunosorbent assay (ELISA) is described for detection of porcine circovirus 2 (PCV2) antibodies using the well-characterized recombinant PCV2 capsid protein. In a comparative test of 394 pig sera against an indirect immunofluorescence (IIF) test and a commercial ELISA kit (also based on the recombinant PCV2 capsid protein), the results showed that the diagnostic sensitivity, specificity, and accuracy of the assay were, respectively, 90.61, 94.02, and 91.62% compared with IIF and 94.38, 95.28, and 94.67% compared with the commercial ELISA kit. Assay of 12 PCV-free pigs over a 5-week period produced only PCV2-negative titers by all 3 methods. These results and the seroprofiles of 4 pig farms obtained by both the commercial ELISA kit and the double-antigen sandwich ELISA indicate that the sandwich ELISA is a reliable method for detection of antibodies to PCV2. Additionally, the method described here permits the use of undiluted test serum samples simultaneously loaded with horseradish peroxidase (HRP)-conjugated antigen into the test well, and the complete test procedure can be performed in less than 90 min. This double-antigen sandwich ELISA should be a useful tool to aid swine industry professionals in deciding the intervention strategies for the control of PCV2-associated diseases.

INTRODUCTION

Porcine circovirus (PCV) is a small nonenveloped virus with a diameter of approximately 17 nm and a circular single-stranded DNA genome (36). There are two known PCV species: PCV1 and PCV2 (35). PCV1 has been identified as a persistent noncytopathic contaminant of the continuous PK15 porcine kidney cell line (37), while PCV2 is often associated with many severe diseases, such as postweaning multisystemic wasting syndrome (PMWS) (1, 8), porcine dermatitis and nephritic syndrome (PDNS) (33), porcine respiratory disease complex (PRDC) (16), reproductive disorders (42), enteritis (17), and proliferative and necrotizing pneumonia (PNP) (7). In coinfections, PCV2 also enhances the severity of the diseases caused by porcine reproductive and respiratory syndrome virus (PRRSV), porcine parvovirus (PPV), swine mycoplasma, Haemophilus parasuis, Streptococcus suis, and other common pathogens of pigs (2, 29, 30) due to its invasion of the immune system. Since PCV2-associated disease is generally recognized as having a significant economic impact on the swine industry worldwide (9), detection and surveillance of PCV2 infection have become important for swine producers.

The PCV2 genome contains two major open reading frames (ORFs), ORF1 and ORF2. ORF1 is essential for viral DNA replication (6), whereas ORF2 encodes a capsid protein involved in the host immune response (3, 15, 18). Capsid protein (Cap) is the only structural protein of PCV2 with good immunogenicity and with a molecular mass of approximately 30 kDa (21). The amino acid sequence identity of Cap between PCV1 and PCV2 is only 65% (27); consequently, although there is some antigenic relationship, only PCV2 Cap protein is recognized by PCV2 polyclonal antibodies, which is the basis for the establishment of methods for specific serological detection of PCV2 (24). Thus, besides indirect immunofluorescence (IIF) (1), immunoperoxidase monolayer assay (IPMA) (8), and some enzyme-linked immunosorbent assays (ELISAs) based on the PCV2 virion (38, 40), more and more ELISAs, mostly indirect, have been developed using recombinant PCV2 Cap protein (4, 20, 25, 28, 34, 44). Here, we report a double-antigen sandwich ELISA, which has certain advantages over current methods for detection of antibodies to PCV2.

MATERIALS AND METHODS

Cells, viruses, and test pig sera.

The porcine PK15 cell line, tested as free of PCV, was maintained in Dulbecco's modified Eagle's medium (DMEM) (Gibco BRL, Grand Island, NY) supplemented with 6% newborn calf serum (NBCS) (Gibco BRL) and 1% antibiotics (100 U of penicillin G per ml, 100 μg of streptomycin sulfate per ml; Gibco BRL). The PCV2 strain YZH (GenBank accession number AY943819) used in the study was isolated from a superficial inguinal lymph node from a pig with naturally occurring PMWS. Three hundred ninety-four serum samples constituted two sets of samples in the research. First, a total of 60 serum samples from 12 PCV-free pigs were collected weekly for 5 weeks (all the serum samples tested PCV negative by PCR detection). Second, 334 serum samples were obtained from four conventional pig farms (A, B, C, and D) with PMWS (farms A and B were the most severely affected, followed by farms C and D). The origins of the serum samples were as follows: 96 serum samples were from farm A (12 serum samples each from 2-, 4-, 6-, 8-, 10-, 12-, and 14-week-old piglets and 12 samples from sows), 108 serum samples were from farm B (12 serum samples each from 0-, 2-, 4-, 6-, 8-, 10-, 12-, and 14-week-old piglets and 12 samples from sows), 70 serum samples were from farm C (10 samples each from 2-, 5-, 8-, 11-, 14-, and 17-week-old piglets and 10 samples from sows), and 60 serum samples were from farm D (12 serum samples each from 4-, 8-, 12-, and 16-week-old piglets and 12 samples from sows). None of the pigs on these farms had been vaccinated against PCV2. Blood samples were clotted and then centrifuged at 1,000 × g for 10 min. The separated serum samples were stored at −20°C until they were used.

Expression, purification, and identification of the recombinant Cap protein.

The following primers were designed according to the genome sequence of PCV2 strain YZH to obtain the target gene, ORF2Δ123 (ORF-2 without the 123-nucleotide [nt] N-terminal signal peptide sequence): upstream, 5′-GCGAATTCGGCATCTTCAACACCCGCCTCTC-3′; downstream, 5′-GCGTCGACTTACTTAGGGTTAAGTGGGGGGTC-3′ (the underlined sequences identify EcoRI and SalI sites). The target gene, ORF2Δ123, was amplified by PCR from the genome of PCV2 mentioned above. The PCR products were double digested with EcoRI and SalI and cloned into the prokaryotic expression vectors pET-28a(+) and pET-32a(+) (containing a thioredoxin [Trx] coding sequences), and the resulting recombinant expression plasmids, pET28a-ORF2Δ123 and pET32a-Δ123, were used to transform competent DH5α cells. Clones containing the recombinant plasmids were identified by restriction enzyme digestion and DNA sequencing (GenScript Corporation, Piscataway, NJ).

For expression of the cloned gene, Rosetta(DE3) pLySs Escherichia coli cells (Novagen, Madison, WI) were transformed with pET28a-ORF2Δ123 and pET32a-ORF2Δ123. The cells were also transformed with plasmid pET-32a(+) for analysis of the Trx protein. Single colonies of transformants were grown in Luria-Bertani (LB) medium at 37°C (with shaking) to an optical density at 600 nm (OD600) of about 0.6, and isopropylthio-β-d-galactopyranoside (IPTG) was added to a final concentration of 1 mM. After induction at 30°C for 6 h, bacteria were collected by centrifugation at 5,000 × g for 10 min. The CapΔ41 protein expressed by pET28a-ORF2Δ123, the Trx-CapΔ41 protein expressed by pET32a-ORF2Δ123, and the Trx protein expressed by pET-32a(+) were purified using the His-Bind Purification kit (Novagen, Madison, WI) according to the manufacturer's instructions. The purified proteins were analyzed by SDS-PAGE and Western blotting.

IIF.

Confluent monolayers of uninfected or PCV2-infected PK-15 cells in 96-well plates (Costar, Corning, NY) were fixed in methanol-acetone (1:1) for 30 min at −20°C, and then the plate was washed 3 times with phosphate-buffered saline (PBS) (pH 7.2). After incubation with 5% skim milk-PBS containing 0.05% Tween 20 (PBST) for 1 h at 37°C, serum samples (50 μl) diluted either 1:20 or 1:100 in PBST were added to the plates and incubated for 1 h at 37°C. Following three washes with PBST, fluorescein-conjugated anti-swine immunoglobulin G (KPL, Gaithersburg, MD) diluted 1:200 was added and incubated for 30 min at 37°C. Fluorescence was observed using an inverted fluorescence microscope (BX51; Olympus, Tokyo, Japan). Serum samples showing positive fluorescence at a serum dilution of 1:20 or higher were considered positive.

PCV2 antibody detection with a commercial ELISA kit.

Besides IIF, a commercial indirect ELISA kit (Jeno Biotech Inc., South Korea) based on recombinant Cap proteins immobilized on ELISA plates for detection of PCV2 antibody was used according to the manufacturer's instructions as another reference method. Based on the determination criteria, the samples were positive if the S/P (sample OD450 - negative-control OD450/positive-control OD450 - negative-control OD450) ratio was ≥0.4, negative if the S/P ratio was <0.3, and equivocal if the S/P ratio was between 0.3 and 0.4.

Preparation of horseradish peroxidase (HRP)-conjugated antigens.

HRP-conjugated antigens (CapΔ41 and Trx-CapΔ41) were prepared according to the procedure described by Wilson and Nakane (43). The conjugate was purified by gel filtration chromatography on a Sephadex G200 column (Amersham Pharmacia Biotech). The purified HRP-conjugated antigens were mixed with an equal volume of glycerin and stored at −20°C.

Optimization of the working conditions of the double-antigen sandwich ELISA.

The optimum concentrations of coating antigen and HRP-conjugated antigens and the ratio of HRP-conjugated antigens to the testing serum were determined by checkerboard serial-dilution analysis. The detailed optimizing process was as follows. CapΔ41 protein was serially diluted 2-fold from 8.0 μg/ml to 0.25 μg/ml in 0.05 M Na bicarbonate/carbonate buffer (pH 9.6). High-binding 96-well microtiter plates (Costar, Corning, NY) were coated with the protein solution at a volume of 100 μl per well at 4°C for 24 h. Thereafter, the wells were washed 3 times with PBST and blocked with 250 μl 5% dried skim milk in 0.01 mM PBST (pH 7.4) at 37°C for 2 h. Following 3 washes with PBST, the plates were dried at room temperature. HRP-conjugated CapΔ41 and HRP-conjugated Trx-CapΔ41 were serially diluted 2-fold from 1:1,000 to 1:8,000 in PBST. Each dilution was mixed with positive- and negative-control sera and with HRP-conjugated antigen and serum in ratios of 1:1, 4:1, 9:1, 19:1, 49:1, and 99:1. Each mixture was made in triplicate, and then 100-μl aliquots of the mixtures were added to the microtitration plate wells. After incubation for 60 min at 37°C followed by 5 rounds of washing with PBST, 50 μl/well of 3,3,5,5-tetramethylethylenediamine solution (SureBlue Reserve TMB Microwell Peroxidase Substrate; KPL) was added and the plates were incubated for 10 min at 37°C. The chromogenic reaction was stopped by the addition of 50 μl 2 M sulfuric acid, and the OD450 was recorded using a microplate reader (MK3; Thermo Labsystem, Helsinki, Finland). The conditions that gave the highest P/N (positive control OD450/negative control OD450) ratios and an OD450 value of positive serum close to 1.0 were considered to be optimal.

Based on the optimized conditions, positive-control and negative-control sera were applied in each test, and the antibody levels of the samples were indicated by S/P ratios calculated according to the following formula: S/P = (sample OD450 − negative-control OD450)/(positive-control OD450 − negative-control OD450). In addition, the detection abilities of HRP-conjugated CapΔ41 and HRP-conjugated Trx-CapΔ41 were compared on 92 of the 334 serum samples to determine which was the more suitable HRP-conjugated antigen for the double-antigen sandwich ELISA.

Confirmation of negative-positive cutoff.

Sixty swine serum samples sequentially collected from 12 PCV-free pigs that tested negative for PCV2 antibody by both IIF and commercial indirect ELISA were tested using the double-antigen sandwich ELISA. The mean S/P ratio (x) and standard deviation (SD) were calculated, and the cutoff value was determined to be x + 3 SD.

Reproducibility of the double-antigen sandwich ELISA.

Evaluation of the assay reproducibility within and between runs was performed as proposed by Jacobson (13). Twelve IIF-positive and 12 IIF-negative field serum samples were selected. For intra-assay (within-plate) reproducibility, three replicates of each serum sample were assigned in the same plate. For interassay (between-run) reproducibility, three replicates of each sample were run in different plates. The mean S/P ratio, SD, and coefficient of variation (CV) were calculated.

Performance evaluation of the double-antigen sandwich ELISA.

Both IIF and the commercial kit were used as reference methods to evaluate the performance of the double-antigen sandwich ELISA. The diagnostic sensitivity (DSN), specificity (DSP), and accuracy were calculated using the following formulae: DSN = TP/(TP + FN) × 100, DSP = TN/(TN + FP) × 100, and accuracy = (TP + TN)/total number of serum samples tested × 100, where TP, FN, TN, and FP represent true positive, false negative, true negative, and false positive, respectively (13). The kappa statistic was used to measure the strength of agreement between the results of the double-antigen sandwich ELISA and the reference methods. A kappa statistic of >0.75 represents excellent agreement, 0.40 to 0.75 good to fair agreement, and <0.40 poor agreement (31).

For further validation of the assay, the mean PCV2 antibody S/P ratios in pigs of different categories from farms A, B, C, and D were calculated, and the overall changes of PCV2 antibody levels in pigs of different age groups were analyzed.

RESULTS

Expression of the recombinant protein.

As determined by agarose gel electrophoresis, the PCR product was about 600 bp, corresponding to the expected size of the cap gene without the nuclear localization signal sequence. Both recombinant expression plasmids pET28a-ORF2Δ123 and pET32a-ORF2Δ123 were successfully constructed and expressed in soluble as well as in inclusion body forms. The approximate molecular masses of the CapΔ41 and Trx-CapΔ41 proteins were 26 kDa and 40 kDa, respectively, which are the corresponding theoretical molecular masses of the fusion proteins (Fig. 1A). The soluble forms of these proteins were used in the subsequent development of the ELISA. Western blot results indicated that the CapΔ41 and Trx-CapΔ41 proteins, but not Trx, were recognized by PCV2-specific polyclonal antibody (Fig. 1B).

Fig 1.

Fig 1

SDS-PAGE and Western blot analysis of purified CapΔ41 and Trx-CapΔ41. (A) Coomassie brilliant blue-stained SDS-PAGE. M, standard molecular marker; lane 1, purified Trx-CapΔ41; lane 2, purified CapΔ41; lane 3, purified Trx. (B) Western blot analysis with swine anti-PCV2 polyclonal antibodies as the primary antibody and with goat anti-swine immunoglobulin G antibody conjugated to HRP as the secondary antibody. Lane 1, Trx; lane 2, CapΔ41; lane 3, Trx-CapΔ41.

Results of IIF testing for PCV2 antibody on serum samples from different pig farms.

Test results for 60 serum samples sequentially collected from the 12 PCV-free pigs were all negative for PCV2 antibodies. Of 334 field sera, 277 samples were positive and 57 samples were negative for PCV2 antibodies. Most of the piglets and sows from farms A, B, C, and D were PCV2 antibody positive. PCV2 antibody-negative samples were mainly from nursery pigs (Table 1).

Table 1.

Detection of antibodies to PCV by IIF in swine serum samples from 4 farms

Farm No. of PCV2-specific serum samples from age group (wk)a or sows:
0 2 4 5 6 8 10 11 12 14 16 17 Sows
A 12 11 10 8 8 9 11 12
B 12 11 9 8 6 9 10 12 11
C 8 8 7 5 8 9 10
D 12 10 7 12 12
a

−, no serum tested. The results are presented as the numbers of IIF-positive sera. In each category, 12, 12, 10, and 12 serum samples, respectively, taken from farms A, B, C, and D were tested. Most 0- to 5-week-old piglets and sows were serum positive for PCV2 antibody. In 6- to 12-week-old piglets, the PCV2-positive rates were lower than in 0- to 5-week-old animals, and most samples showed only low fluorescence.

Working conditions of the double-antigen sandwich ELISA.

The optimal working conditions were 100 ng/well of the coating antigen combined with 1:4,000-diluted HRP-Trx-CapΔ41-conjugated antigen and 1:10 dilution of serum sample, which gave an OD450 value of around 1.0 for the positive-control serum and the highest P/N ratio of 12. 27 ± 0.45. The results of the comparative study with the 92 serum samples showed that the sensitivity of the HRP-CapΔ41-based ELISA was not as high as that of the HRP-Trx-CapΔ41-based ELISA, particularly with positive serum samples taken shortly after seroconversion (some data are shown in Table 2). Therefore, HRP-Trx-CapΔ41 was chosen as the HRP-conjugated antigen for the double-antigen sandwich ELISA.

Table 2.

Comparison of HRP-Trx-CapΔ41 and HRP-CapΔ41-based ELISAs

Serum no. S/P ratio
HRP-Trx-CapΔ41 HRP-CapΔ41
Positivea
    A2-1 1.337 1.124
    A2-2 0.997 0.961
    B4-1 0.624 0.685
    B4-2 0.732 0.648
    A14-1 0.902 0.775
    A14-2 0.557 0.489
    B14-1 1.083 0.921
    B14-2 1.194 1.040
Positive/negativeb
    A12-1 0.813 0.106
    A12-3 0.458 0.109
    A12-5 0.760 0.113
    A12-7 0.497 0.104
    B10-1 0.626 0.137
    B10-2 0.665 0.185
    B10-3 0.358 0.135
    B10-4 0.517 0.089
a

Eight serum samples of the 92 sera testing positive for PCV2 antibody by HRP-Trx-CapΔ41- and HRP-CapΔ41-based ELISA.

b

Eight serum samples taken shortly after seroconversion of the 92 sera testing positive for PCV2 antibody by HRP-Trx-CapΔ41-based ELISA but negative by HRP-CapΔ41-based ELISA.

Reproducibility of double-antigen sandwich ELISA.

The reproducibility of the ELISA was determined by comparing the S/P ratios of each serum sample. The intra-assay CV of the 12 positive serum samples tested ranged from 2.06% to 8.27%, with a median value of 5.16%, whereas the interassay CV of these samples ranged between 3.32% and 12.73%, with a median value of 7.95%. In addition, the ELISA also showed good repeatability for 12 negative field sera (data not shown). These data indicated that the double-antigen sandwich ELISA was repeatable with low variation.

Confirmation of negative-positive cutoff.

The mean S/P ratios (x) and SD of the 60 negative sera were calculated as 0.088 and 0.059, respectively. The negative-positive cutoff S/P value of approximately 0.27 was obtained based on the formula x + 3 SD.

Performance evaluation of the double-antigen sandwich ELISA.

The sensitivity and specificity of the double-antigen sandwich ELISA were evaluated in comparison to those of IIF and the commercial ELISA kit. Based on the results of the 394 serum samples tested by the three methods (Table 3), the DSN and DSP of the ELISA were calculated as 90.61% and 94.02%, respectively, compared with IIF and 94.38% and 95.28% compared with the commercial kit. The positive rates of the 334 field serum samples by IIF, the commercial kit, and double-antigen sandwich ELISA were 82.93, 79.94, and 77.25%, respectively. The agreement between the double-antigen sandwich ELISA and IIF was excellent, with a kappa value of 0.808, and that between the double-antigen sandwich ELISA and the commercial indirect ELISA kit was also excellent, with a kappa value of 0.88.

Table 3.

Comparison of double-antigen sandwich ELISA with IIF and commercial indirect ELISA kit

Double-antigen sandwich ELISA resulta No. of serum samples
IIF
Commercial kitb
Positive Negative Total Positive Negative Total
Positive 251 7 258 252 6 258
Negative 26 110 136 15 121 136
Total 277 117 394 267 127 394
a

S/P ratio cutoffs: positive, ≥0.27; negative, <0.27.

b

For better statistical analysis, the S/P ratio cutoffs of the commercial kit were adjusted as follows: positive, ≥0.35; negative, <0.35 (the original S/P ratio cutoffs were positive, ≥0.40; equivocal, ≥0.30 and <0.40; negative, <0.30).

Serum samples from the 12 PCV-free pigs tested negative for PCV2 antibodies by both double-antigen sandwich ELISA and the commercial indirect ELISA kit over the entire 5-week test period (Fig. 2). Seroprofiles based on the mean PCV2 antibody titers over the time covering the whole growth stages of pigs from farms A, B, C, and D are shown in Fig. 3. Similar results were obtained with both the commercial indirect ELISA and the double-antigen sandwich ELISA. All four farms showed seroconversion with similar serological profiles. Initially, the newborns had varying levels of maternal antibody, which declined gradually with the growth of piglets. On farms A, B, C, and D, titers were lowest at 10, 8, 11, and 12 weeks of age, respectively, with all increasing to adult levels over the next 4 weeks.

Fig 2.

Fig 2

Mean PCV2-specific serum antibody titers of 12 PCV-free pigs over a 5-week period. Standard deviations are indicated by the error bars. The S/P cutoffs of the commercial indirect ELISA kit and the double-antigen sandwich ELISA were 0.4 and 0.27, respectively.

Fig 3.

Fig 3

Mean PCV2-specific serum antibody titers of pigs in different categories from farms A (A), B (B), C (C), and D (D). Standard deviations are indicated by the error bars. The S/P cutoffs of the commercial indirect ELISA kit and the double-antigen sandwich ELISA were 0.4 and 0.27, respectively.

DISCUSSION

Several indirect ELISAs using the recombinant Cap protein expressed in insect cells or E. coli as a coating antigen have been described (4, 20, 25, 28, 34, 44). These studies indicated that the recombinant PCV2 Cap protein expressed in either prokaryotes or eukaryotes showed good immunoreactivity and that these proteins were effective diagnostic antigens for establishment of an ELISA method for PCV2 epidemiological investigation and clinical diagnosis. However, the prokaryotic expression system is easier to use in terms of cost and time saving. In the present study, therefore, prokaryotic expression was chosen to produce the recombinant PCV2 Cap protein to develop the double-antigen sandwich ELISA.

Cap protein encoded by the ORF2 gene contains a nuclear localization signal (NLS) of 41 amino acids at its N terminus (22), which seriously affects the heterologous expression of the Cap protein in E. coli (39). Fortunately, it has been reported that this NLS has poor reactivity with PCV2-positive swine sera and that deletion of NLS has little effect on the immunoreactivity of the Cap protein (18, 44). Therefore, the 41-amino-acid signal peptide sequence at the 5′ end of the ORF2 gene was deleted, and the resulting ORF2 gene was inserted into the pET28-a(+) and pET32-a(+) expression vectors to construct recombinant plasmids pET28a-ORF2Δ123 and pET32a-ORF2Δ123. Instead of using the inclusion body form of the recombinant Cap protein, which required renaturation before developing the ELISA, we used the soluble form of the protein to establish the double-antigen sandwich ELISA because of its good immunoreactivity without a need for renaturation. While establishing the double-antigen sandwich ELISA using either HRP-CapΔ41 or HRP-Trx-CapΔ41 as the conjugated antigen, we found that inconsistent test results were observed with some positive serum samples, mainly from 10- to 12-week-old pigs shortly after seroconversion. Antibodies in these samples were recognized by HRP-Trx-CapΔ41, but not by HRP-CapΔ41. This is probably due to the modification of some epitopes on the CapΔ41 protein during HRP conjugation, resulting in loss of specific binding activity to serum PCV2 antibody. In this study, the conjugation method was based on the principle that HRP conjugated to a protein by the reaction between the aldehyde group (formed by oxidization of the hydroyxl group) of HRP and a primary amine on a protein and lysine side chain ε-amines on proteins are primary amine groups which are usually present in abundant quantities for modification or conjugation reactions (11). In recombinant Trx-CapΔ41, there are 21 lysine residues, with 8 in CapΔ41 and 13 in Trx. Consequently, the proportion of HRP conjugated to Trx will likely be greater than that conjugated to CapΔ41. Conjugation of HRP to Trx may therefore have spared the important CapΔ41 epitopes in Trx-CapΔ41 conjugates, resulting in higher detection sensitivity in the double-antigen sandwich ELISA.

IIF is a traditional and classical method for immunodetection, especially for those viruses in which cross-reactivity is not a problem. However, there is cross-reactivity between the Rep proteins of PCV1 and PCV2, so the cross-reaction of IIF on PCV1-infected PK15 cells and on PCV2-infected PK15 cells exists (23). This may explain why the positive rate obtained by IIF was higher than that obtained by the ELISAs with the Cap protein as a coating antigen and may explain why such ELISAs have higher specificity than IIF for PCV2 antibody detection. Despite previous studies describing the high prevalence of PCV1 in swine herds, recent investigations have shown that the prevalence of PCV1 is low in PCV field cases, with PCV2 being the prevailing strain (32). This may explain why the incidence of PCV2 as measured by IIF was in good agreement but slightly higher than with the ELISAs.

Compared with IIF, the commercial indirect ELISA is the main reference method concerned, because there are more common characteristics between the indirect and double-antigen sandwich ELISA. The concordance of the two methods is excellent, but the double-antigen sandwich ELISA may be superior and more suitable for detection of antibodies to PCV2. In recent years, the double-antigen sandwich assay has been used for detection of antibodies to several viruses and toxin, including human hepatitis B virus (19), hepatitis C virus (10), hepatitis E virus (12), influenza A virus (41), rabies virus (45), and verocytotoxin (26), and some clinical trials have shown that the assay is more sensitive and specific than the indirect assay (19, 26). In the indirect ELISA system, some of the nonspecific IgG antibodies in the test serum with strong binding ability may be directly adsorbed to either the solid-phase carrier or the surface of the coated antigen, and these nonspecifically bound antibodies, which are not removed in subsequent washing steps, bind to the conjugated secondary antibodies, resulting in a high background or false-positive reactions (10, 26). Instead of using conjugated secondary antibodies in the indirect ELISA, conjugated antigens were used in double-antigen sandwich ELISA. Therefore, in the double-antigen sandwich ELISA system, serum specific IgG antibody binds to the antigen on the solid phase by one of the two binding sites and captures the conjugated antigen in the liquid phase with the other. Even if the nonspecific IgG molecules attached to the solid phase, they would not capture the conjugated antigen. Thus, double-antigen ELISA generally exhibits low backgrounds. This was demonstrated in the present work, in which the OD450 values of most of the negative sera were below 0.1 by the double-antigen ELISA but between 0.1and 0.3 in the commercial indirect ELISA (data not shown). Improving the specificity of an indirect ELISA generally requires preparation of high dilutions of test sera, which is inconvenient and prone to dilution error or might decrease sensitivity, whereas the double-antigen sandwich ELISA can be performed without sample dilution (10), which increases sensitivity and simplifies the procedure.

Serological analysis performed on pigs at farms A and B, with severe PMWS; at farm C, with less severe PMWS; and at farm D, with mild PMWS, provided a further check on the validity of the double-antigen sandwich ELISA for detection of antibodies against PCV2. Seroconversion was found to occur earlier at farms A and B than at farms C and D, indicating a relationship between the time of seroconversion and the severity of the disease, i.e., seroconversion occurred earlier in pigs that developed more severe PMWS. This observation is similar to a previous report that seroconversion on PMWS-affected farms appeared earlier than on non-PMWS-affected farms (4). The double-antigen sandwich ELISA indicates similar serological profiles for the 4 farms, which were consistent with the profiles obtained by the reference commercial indirect ELISA and also in agreement with results of previous reports (5, 14, 25).

In conclusion, this is the first report of a sensitive and specific double-antigen sandwich ELISA for detection of PCV2 antibody. Compared with other ELISA methods, this technique is rapid and simple and should prove to be a useful tool for detection of PCV2 antibodies in pigs.

ACKNOWLEDGMENT

This work was supported by the National Natural Science Foundation of China (grant no. 30972167).

Footnotes

Published ahead of print 18 July 2012

REFERENCES

  • 1. Allan GM, et al. 1998. Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the U. S. A. and Europe. J. Vet. Diagn. Invest. 10:3–10 [DOI] [PubMed] [Google Scholar]
  • 2. Allan GM, et al. 2000. Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication. Arch. Virol. 145:2421–2429 [DOI] [PubMed] [Google Scholar]
  • 3. Blanchard P, et al. 2003. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 21:4565–4575 [DOI] [PubMed] [Google Scholar]
  • 4. Blanchard P, et al. 2003. An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome. Vet. Microbiol. 94:183–194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Carasova P, et al. 2007. The levels of PCV2 specific antibodies and viremia in pigs. Res. Vet. Sci. 83:274–278 [DOI] [PubMed] [Google Scholar]
  • 6. Cheung AK. 2004. Identification of an octanucleotide motif sequence essential for viral protein, DNA, and progeny virus biosynthesis at the origin of DNA replication of porcine circovirus type 2. Virology 324:28–36 [DOI] [PubMed] [Google Scholar]
  • 7. Drolet R, Larochelle R, Morin M, Delisle B, Magar R. 2003. Detection rates of porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, and swine influenza virus in porcine proliferative and necrotizing pneumonia. Vet. Pathol. 40:143–148 [DOI] [PubMed] [Google Scholar]
  • 8. Ellis J, et al. 1998. Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can. Vet. J. 39:44–51 [PMC free article] [PubMed] [Google Scholar]
  • 9. Gillespie J, Opriessnig T, Meng XJ, Pelzer K, Buechner-Maxwell V. 2009. Porcine circovirus type 2 and porcine circovirus-associated disease. J. Vet. Intern. Med. 23:1151–1163 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. He J, et al. 2011. Double-antigen sandwich ELISA for the detection of anti-hepatitis C virus antibodies. J. Virol. Methods 171:163–168 [DOI] [PubMed] [Google Scholar]
  • 11. Hermanson GT. 2008. Bioconjugate techniques, 2nd ed, p 114 Academic Press, San Diego, CA [Google Scholar]
  • 12. Hu WP, et al. 2008. Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera. Clin. Vaccine Immunol. 15:1151–1157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Jacobson RH. 1998. Validation of serological assays for diagnosis of infectious diseases. Rev. Sci. Tech. 17:469–526 [DOI] [PubMed] [Google Scholar]
  • 14. Kekarainen T, et al. 2010. Immune responses and vaccine induced immunity against porcine circovirus type 2. Vet. Immunol. Immunopathol. 136:185–193 [DOI] [PubMed] [Google Scholar]
  • 15. Khayat R, et al. 2011. The 2.3-angstrom structure of porcine circovirus 2. J. Virol. 85:7856–7862 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Kim J, Chung HK, Chae C. 2003. Association of porcine circovirus 2 with porcine respiratory disease complex. Vet. J. 166:251–256 [DOI] [PubMed] [Google Scholar]
  • 17. Kim J, Ha Y, Jung K, Choi C, Chae C. 2004. Enteritis associated with porcine circovirus 2 in pigs. Can. J. Vet. Res. 68:218–221 [PMC free article] [PubMed] [Google Scholar]
  • 18. Lekcharoensuk P, et al. 2004. Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. J. Virol. 78:8135–8145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Li A, et al. 2010. Novel double-antigen sandwich immunoassay for human hepatitis B core antibody. Clin. Vaccine Immunol. 17:464–469 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Liu C, Ihara T, Nunoya T, Ueda S. 2004. Development of an ELISA based on the baculovirus-expressed capsid protein of porcine circovirus type 2 as antigen. J. Vet. Med. Sci. 66:237–242 [DOI] [PubMed] [Google Scholar]
  • 21. Liu Q, Willson P, Attoh-Poku S, Babiuk LA. 2001. Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein. Protein Expr. Purif. 21:115–120 [DOI] [PubMed] [Google Scholar]
  • 22. Liu Q, Tikoo SK, Babiuk LA. 2001. Nuclear localization of the ORF2 protein encoded by porcine circovirus type 2. Virology 285:91–99 [DOI] [PubMed] [Google Scholar]
  • 23. Magar R, Muller P, Larochelle R. 2000. Retrospective serological survey of antibodies to porcine circovirus type 1 and type 2. Can. J. Vet. Res. 64:184–186 [PMC free article] [PubMed] [Google Scholar]
  • 24. Mahé D, et al. 2000. Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J. Gen. Virol. 81:1815–1824 [DOI] [PubMed] [Google Scholar]
  • 25. Marcekova Z, et al. 2009. Heterologous expression of full-length capsid protein of porcine circovirus 2 in Escherichia coli and its potential use for detection of antibodies. J. Virol. Methods 162:133–141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Miyazawa H, et al. 1999. A reverse-sandwich enzyme-linked immunosorbent assay for verocytotoxin 1 and 2 antibodies in human and bovine sera. Clin. Diagn. Lab. Immunol. 6:701–704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Morozov I, et al. 1998. Detection of a novel strain of porcine circovirus in pigs with postweaning multisystemic wasting syndrome. J. Clin. Microbiol. 36:2535–2541 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Nawagitgul P, et al. 2002. Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV. Clin. Diagn. Lab. Immunol. 9:33–40 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Opriessnig T, et al. 2004. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet. Pathol. 41:624–640 [DOI] [PubMed] [Google Scholar]
  • 30. Opriessnig T, Meng XJ, Halbur PG. 2007. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J. Vet. Diagn. Invest. 19:591–615 [DOI] [PubMed] [Google Scholar]
  • 31. Pottumarthy S, Morris AJ, Harrison AC, Wells VC. 1999. Evaluation of the tuberculin gamma interferon assay: potential to replace the Mantoux skin test. J. Clin. Microbiol. 37:3229–3232 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Puvanendiran S, et al. 2011. Absence of porcine circovirus type 1 (PCV1) and high prevalence of PCV2 exposure and infection in swine finisher herds. Virus Res. 157:92–98 [DOI] [PubMed] [Google Scholar]
  • 33. Rosell C, et al. 2000. Identification of porcine circovirus in tissues of pigs with porcine dermatitis and nephropathy syndrome. Vet. Rec. 146:40–43 [DOI] [PubMed] [Google Scholar]
  • 34. Shang SB, et al. 2008. Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2. Res. Vet. Sci. 84:150–157 [DOI] [PubMed] [Google Scholar]
  • 35. Tattersall P, et al. 2005. Family Parvoviridae, p 353–369 In Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. (ed), Virus taxonomy: classification and nomenclature of viruses. Eighth Report of the International Committee on the Taxonomy of Viruses. Elsevier Academic Press, London, United Kingdom [Google Scholar]
  • 36. Tischer I, Gelderblom H, Vettermann W, Koch MA. 1982. A very small porcine virus with a circular single-stranded DNA. Nature 295:64–66 [DOI] [PubMed] [Google Scholar]
  • 37. Tischer I, Mields W, Wolff D, Vagt M, Griem W. 1986. Studies on epidemiology and pathogenicity of porcine circovirus. Arch. Virol. 91:271–276 [DOI] [PubMed] [Google Scholar]
  • 38. Tischer I, Bode L, Peters D, Pociuli S, Germann B. 1995. Distribution of antibodies to porcine circovirus in swine populations of different breeding farms. Arch. Virol. 140:737–743 [DOI] [PubMed] [Google Scholar]
  • 39. Trundova M, Celer V. 2007. Expression of porcine circovirus 2 ORF2 gene requires codon optimized E. coli cells. Virus Genes 34:199–204 [DOI] [PubMed] [Google Scholar]
  • 40. Walker IW, et al. 2000. Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2. J. Vet. Diagn. Invest. 12:400–405 [DOI] [PubMed] [Google Scholar]
  • 41. Watcharatanyatip K, et al. 2010. Multispecies detection of antibodies to influenza A viruses by a double-antigen sandwich ELISA. J. Virol. Methods 163:238–243 [DOI] [PubMed] [Google Scholar]
  • 42. West KH, et al. 1999. Myocarditis and abortion associated with intrauterine infection of sows with porcine circovirus 2. J. Vet. Diagn. Invest. 11:530–532 [DOI] [PubMed] [Google Scholar]
  • 43. Wilson MB, Nakane PK. 1978. Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies, p 215–224 In Knapp W, Wick G, Holubar K. (ed), Immunofluorescence and related staining techniques. Elsevier, Amsterdam, The Netherlands [Google Scholar]
  • 44. Wu PC, et al. 2008. Expression of the porcine circovirus type 2 capsid protein subunits and application to an indirect ELISA. J. Biotechnol. 133:58–64 [DOI] [PubMed] [Google Scholar]
  • 45. Yang LM, Zhao LZ, Hu RL, Shi ZS, Liu WJ. 2006. A novel double-antigen sandwich enzyme-linked immunosorbent assay for measurement of antibodies against rabies virus. Clin. Vaccine Immunol. 13:966–968 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Vaccine Immunology : CVI are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES